• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体外循环对芬太尼分布和消除的影响。

Effect of cardiopulmonary bypass on fentanyl distribution and elimination.

作者信息

Koska A J, Romagnoli A, Kramer W G

出版信息

Clin Pharmacol Ther. 1981 Jan;29(1):100-5. doi: 10.1038/clpt.1981.16.

DOI:10.1038/clpt.1981.16
PMID:6970110
Abstract

Fentanyl kinetics was studied in two groups of six patients, one group undergoing surgery with and one without cardiopulmonary bypass; the latter served as the controls. Plasma fentanyl concentrations declined biexponentially in the control patients with an average half-life (t1/2 beta) of 3.3 +/- 1.1 hr, total plasma clearance of 11.2 +/- 3.4 ml/min/kg, and volume of distribution (Vd beta) of 3.2 +/- 1.5 l/kg. The plasma concentration/time curves were severely disrupted during cardiopulmonary bypass but appeared to regain a log-linear decay once bypass was complete. This elimination phase had a t1/2 of 5.2 +/- 2.7 hr, longer than that in the control patients. Since fentanyl is eliminated primarily by hepatic metabolism, decreased liver plasma flow observed during and after bypass, as evidenced by a 30% decrease in indocyanine green clearance, may contribute to the extended t1/2. The prolonged t1/2 had clinical importance because of potentially prolonged effects and their relation to other drugs and the clinical management of the patient.

摘要

在两组各六名患者中研究了芬太尼的动力学,一组患者进行了体外循环手术,另一组未进行体外循环手术,后者作为对照组。在对照组患者中,血浆芬太尼浓度呈双指数下降,平均半衰期(t1/2β)为3.3±1.1小时,血浆总清除率为11.2±3.4毫升/分钟/千克,分布容积(Vdβ)为3.2±1.5升/千克。在体外循环期间,血浆浓度/时间曲线严重紊乱,但一旦体外循环结束,似乎又恢复了对数线性衰减。这个消除阶段的t1/2为5.2±2.7小时,比对照组患者的t1/2长。由于芬太尼主要通过肝脏代谢消除,体外循环期间和之后观察到肝脏血浆流量减少,如吲哚菁绿清除率下降30%所证明的,这可能导致t1/2延长。t1/2延长具有临床重要性,因为其效应可能会延长,并且与其他药物以及患者的临床管理有关。

相似文献

1
Effect of cardiopulmonary bypass on fentanyl distribution and elimination.体外循环对芬太尼分布和消除的影响。
Clin Pharmacol Ther. 1981 Jan;29(1):100-5. doi: 10.1038/clpt.1981.16.
2
Fentanyl pharmacokinetics in anaesthetized patients with cirrhosis.芬太尼在肝硬化麻醉患者中的药代动力学。
Br J Anaesth. 1982 Dec;54(12):1267-70. doi: 10.1093/bja/54.12.1267.
3
Papaverine disposition in cardiac surgery patients and the effect of cardiopulmonary bypass.罂粟碱在心脏手术患者中的处置及体外循环的影响。
Eur J Clin Pharmacol. 1984;27(2):127-30. doi: 10.1007/BF00544033.
4
Indocyanine green clearance after cardiac surgery: the impact of cardiopulmonary bypass.心脏手术后的吲哚菁绿清除率:体外循环的影响。
Perfusion. 2012 Jul;27(4):292-9. doi: 10.1177/0267659112439596. Epub 2012 Feb 21.
5
Effect of cardiopulmonary bypass on the plasma concentrations of fentanyl and alcuronium.体外循环对芬太尼和阿库氯铵血浆浓度的影响。
J Clin Pharm Ther. 1997 Jun;22(3):197-205. doi: 10.1046/j.1365-2710.1997.94875948.x.
6
Pharmacokinetics of high-dose fentanyl. A study in patients undergoing cardiac surgery.大剂量芬太尼的药代动力学。一项针对心脏手术患者的研究。
Br J Anaesth. 1980 Aug;52(8):795-801. doi: 10.1093/bja/52.8.795.
7
[Hepatic elimination of thiopental in heart surgery patients].
Anaesthesist. 1992 Apr;41(4):171-8.
8
The influence of hypothermia on the disposition of fentanyl--human and animal studies.
Eur J Clin Pharmacol. 1987;32(4):373-6. doi: 10.1007/BF00543972.
9
Fentanyl sequestration in lungs during cardiopulmonary bypass.体外循环期间芬太尼在肺中的潴留
Clin Pharmacol Ther. 1983 Nov;34(5):703-6. doi: 10.1038/clpt.1983.235.
10
The influence of hepatic plasma flow on alfentanil plasma concentration plateaus achieved with an infusion model in humans: measurement of alfentanil hepatic extraction coefficient.
Anesth Analg. 1986 Oct;65(10):999-1003.

引用本文的文献

1
CYP2D6 pharmacogenetic and oxycodone pharmacokinetic association study in pediatric surgical patients.小儿外科患者中CYP2D6药物遗传学与羟考酮药代动力学的关联研究
Pharmacogenomics. 2017 Mar;18(4):337-348. doi: 10.2217/pgs-2016-0183. Epub 2017 Feb 17.
2
The impact of extracorporeal life support and hypothermia on drug disposition in critically ill infants and children.体外生命支持和低温对危重症婴儿和儿童药物处置的影响。
Pediatr Clin North Am. 2012 Oct;59(5):1183-204. doi: 10.1016/j.pcl.2012.07.013. Epub 2012 Aug 29.
3
Impact of obesity on drug metabolism and elimination in adults and children.
肥胖对成人和儿童药物代谢和消除的影响。
Clin Pharmacokinet. 2012 May 1;51(5):277-304. doi: 10.2165/11599410-000000000-00000.
4
Effect of surgery and cardiopulmonary bypass on indocyanine green pharmacokinetics.手术及体外循环对吲哚菁绿药代动力学的影响。
Tex Heart Inst J. 1986 Mar;13(1):77-82.
5
Pharmacodynamics of fentanyl citrate in patients undergoing aortocoronary bypass.枸橼酸芬太尼在接受主动脉冠状动脉旁路移植术患者中的药效学
Cardiovasc Dis. 1981 Sep;8(3):405-412.
6
Pharmacokinetics of opioids in liver disease.阿片类药物在肝脏疾病中的药代动力学。
Clin Pharmacokinet. 1999 Jul;37(1):17-40. doi: 10.2165/00003088-199937010-00002.
7
Clinical pharmacokinetics of alfentanil, fentanyl and sufentanil. An update.阿芬太尼、芬太尼和舒芬太尼的临床药代动力学。最新进展。
Clin Pharmacokinet. 1996 Oct;31(4):275-92. doi: 10.2165/00003088-199631040-00004.
8
Anaesthesia for coronary artery surgery--a plea for a goal-directed approach.冠状动脉手术的麻醉——呼吁采用目标导向方法。
Can J Anaesth. 1993 Dec;40(12):1178-94. doi: 10.1007/BF03009608.
9
Effect of cardiopulmonary bypass on the pharmacokinetics of drugs.体外循环对药物药代动力学的影响。
Clin Pharmacokinet. 1982 May-Jun;7(3):234-51. doi: 10.2165/00003088-198207030-00004.
10
Alcuronium kinetics in patients undergoing cardiopulmonary bypass surgery.体外循环心脏手术患者中阿库氯铵的药代动力学
Br J Clin Pharmacol. 1983 Feb;15(2):237-44. doi: 10.1111/j.1365-2125.1983.tb01492.x.